Back to stocks
GENB

GENB

Generate Biomedicines, Inc.

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
21
Partial Q3 2026
Total 13F value
$34.2M
Filed positions so far
New positions
12
This quarter
Sold positions
2
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Banque Pictet & Cie Sa

$26.6M1.77M0.18%New Position

Alps Advisors Inc

$2.6M170.0K0.01%+31.4%

Sumitomo Mitsui Trust Group, Inc.

$1.2M78.5K0.00%+103.1%

Bank Pictet & Cie (Europe) Ag

$1.2M77.8K0.02%New Position

Centerbook Partners Lp

$651K43.4K0.03%-67.0%

Dynamic Advisor Solutions Llc

$613K40.8K0.02%New Position

Magnus Financial Group Llc

$327K21.8K0.02%+39.4%

Tema Etfs Llc

$305K20.3K0.01%New Position

Pictet Bank & Trust Ltd

$250K16.7K0.29%New Position

Summa Corp.

$250K16.7K0.05%New Position

Parallel Advisors, Llc

$176K11.7K0.00%+4.8%

Albion Financial Group /Ut

$73K4.9K0.00%Unchanged

State Of Wyoming

$14K9330.00%-33.7%

Sterling Capital Management Llc

$11K7010.00%+230.7%

Td Waterhouse Canada Inc.

$8K5730.00%Unchanged

Parkside Financial Bank & Trust

$1K950.00%New Position

Root Financial Partners, Llc

$811540.00%New Position

Gamma Investing Llc

$706470.00%New Position

Farther Finance Advisors, Llc

$165110.00%New Position

Sjs Investment Consulting Inc.

$7650.00%New Position

Covestor Ltd

$0210.00%New Position

Explore